Chemistry: molecular biology and microbiology – Enzyme – proenzyme; compositions thereof; process for... – Hydrolase
Patent
1999-05-07
2000-05-23
Patterson, Jr., Charles L.
Chemistry: molecular biology and microbiology
Enzyme , proenzyme; compositions thereof; process for...
Hydrolase
4352523, 4353261, 536 232, C12N 922, C12N 1555
Patent
active
060664878
ABSTRACT:
BsrFI restriction enzyme was purified from Bacillus stearothermophilus to near homogeneity. The protein was sequenced to obtain its N-terminus amino acid sequence. A set of denegerate primers were synthesized based on the aa sequence. The first 18 codons encoding BsrFI restriction endonuclease (bsrFIR) was amplified by PCR and its coding sequence was obtained. The methylase selection method was used to clone BsrFI methylase gene (bsrFIM). Two clones were found to be resistant to BsrFI digstion. The entire insert in one clone was sequenced and the insert encodes the BsrFI methylase (M. BsrFI). In addition, a small truncated open reading frame adjacent to the methylase gene has homology to Cfr10I restriciton endonuclease in a BlastX homology search in Genbank database. BsrFI and Cfr10I are isoschizomer that recognizes and cleaves 5'R CCGGY3'. Two primers were used to amplify the bsrFIR gene, The forward primer is a degenerate primer designed from the N-terminus aa sequence and the reverse primer is the bona fide sequence derived from the BsrFI methylase.sup.+ clone. The bsrFIR gene was amplified by PCR, ligated into a T7 expression vector pET21at and the ligated DNA was transformed into premodified cells ER2566 [pLG339-BsrFIM]. The final expression strain is ER2566 [pLG339-BsrFIM, pET21at-BsrFIR]. Recombinant BsrFI activity was detected in E. coli cell extract. BsrFI is cloned from a thermophile Bacillus stearothermophilus. Thus, BsrFI a thermostable enzyme and it is active at 37.degree. C. to 65.degree. C.
REFERENCES:
patent: 5200333 (1993-04-01), Wilson
patent: 5498535 (1996-03-01), Fomenkov et al.
Roberts and Macelis, Nucl. Acids Res. 27: 312-313, (1999).
Kosykh et al, Mol. Gen. Genet. 178: 717-719 (1980).
Mann et al, Gene 3: 97-112, (1978).
Walder et al, Proc. Nat. Acad. Sci. 78: 1503-1507,(1981).
Bougueleret et al, Nucl. Acids Res. 12: 3659-3676, (1984).
Gingeras and Brooks, Proc. Natl. Acad. Sci. USA 80: 402-406, (1983).
Theriault and Roy, Gene 19: 355-359, (1985).
Blumenthal et al, J. Bacteriol. 164: 501-509, (1985).
Wayne et al, Gene 202: 83-88, (1997).
Kiss et al, Nucl. Acids Res. 13: 6403-6421, (1985).
Szomolanyi et al, Gene 10: 219-225, (1980).
Janulaitis et al, Gene 20: 197-204, (1982).
Kiss and Baldauf, Gene 21: 111-119, (1983).
Walder et al, J. Biol. Chem. 258: 1235-1241, (1983).
Fomenkov et al, Nucl. Acids Res. 22: 2399-2403, (1994).
Xiao Jian-ping
Xu Shuang-yong
New England Biolabs Inc.
Patterson Jr. Charles L.
Williams Gregory D.
LandOfFree
Method for cloning and expression of BsrFI restriction endonucle does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for cloning and expression of BsrFI restriction endonucle, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for cloning and expression of BsrFI restriction endonucle will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1836136